WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF ...

Willow Biosciences To Commence Trading on The OTCQB ...

CALGARY, Alberta, November 5, 2019 — Willow Biosciences Inc. (“Willow” or the “Company”) (CSE:WLLW; OTCQB:CANSF) is pleased to announce that it has been ...

Willow Bioscience agrees to partnership with biotech ... - YouTube

Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share news ... Willow Biosciences announces Astaxanthin will be ...

WILLOW BIOSCIENCES ANNOUNCES PRICING AND UPSIZE OF ...

Vancouver, British Columbia – October 21, 2020 – Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW; OTCQX: CANSF) is pleased to announce that, ...

WILLOW BIOSCIENCES AND CELLULAR GOODS ANNOUNCE ...

In April 2021, Willow announced that it has completed a series of studies with its development partner, Signum Biosciences, Inc., that demonstrate the safety ...

Makena Resources Inc., Biocan Technologies Inc. and Epimeron Inc ...

Announce Completion of Private Placement, Strategic Investment From Tuatara Capital and Business Combination to Form Willow Biosciences Inc. VANCOUVER and ...

WILLOW BIOSCIENCES ANNOUNCESANNUAL GENERAL AND ...

Sunnyvale, California – July 26, 2024 – Willow Biosciences Inc.("Willow" or the "Company") (TSX: WLLW; OTCQB: CANSF) is pleased to announce the voting ...

Collaboration provides Laurus access to Willow's AI-driven ...

WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS.

WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 ...

On June 26, 2024, Willow announced a new feasibility study for a partnership with an innovative Ag-Biotech company to apply its technology platform to ...

WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2023 ...

On September 6, 2023, Willow announced that it had successfully completed the research and development program on cost-effective, sustainably produced ...

WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 ...

On January 16, 2024, Willow announced a new collaboration with Enterin, Inc., a clinical stage biopharmaceutical innovator to develop a new sustainable ...

WILLOW BIOSCIENCES ANNOUNCES NEW FUNCTIONAL ...

Willow has completed proof of concept work, and development is currently underway to establish a commercial production process for pure, ...

News - Willow Biosciences

Latest news, media & events · WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE · WILLOW BIOSCIENCES ANNOUNCES NEW ...

WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL SCALE ...

In March 2021, Willow completed its first commercial scale fermentation run of cannabigerol (“CBG”) with its manufacturing partner at their ...

WILLOW BIOSCIENCES ANNOUNCES IT HAS COMMENCED ITS ...

Vancouver, British Columbia – July 29, 2020 – Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW; OTCQX: CANSF) is pleased to ...

WILLOW BIOSCIENCES ANNOUNCESANNUAL GENERAL AND ...

Mountain View, California – May 12, 2023 – Willow Biosciences Inc.(“Willow” or the “Company“) (TSX: WLLW; OTCQB: CANSF) is pleased to announce the voting ...

WILLOW ANNOUNCES COMMERCIAL AGREEMENT WITH ...

Willow previously announced the successful results from the application of its BioOxiTM bio-oxidation platform to the development of a key step ...

WILLOW ANNOUNCES FOLLOW-ON ENGAGEMENT FOR NEXT ...

Calgary, Alberta and Mountain View, California – January 16, 2023 – Willow Biosciences Inc. ... This represents the continuation of the project, ...

WILLOW BIOSCIENCES ANNOUNCES GROUND-BREAKING ...

(“Willow” or the “Company“) (TSX: WLLW; OTCQX: CANSF) is pleased to announce that it has completed a series of studies with its development ...

WILLOW BIOSCIENCES ANNOUNCES EXPANSION OF ITS ...

ancouver, British Columbia – July 20, 2021 – Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW; OTCQX: CANSF), ...

WILLOW BIOSCIENCES ANNOUNCES EXPEDITED PILOT ...

We expect to offer a portfolio of ultra-pure, pharmaceutical grade quality cannabinoids by the end of 2021. As we transition from a research- ...